| |
|
|
|
|
| February 25,
2010 | ISSUE NUMBER 137 VOL 8 |
M&A
Astellas’ Hostile Takeover Turns Even More Hostile
The Japan-based company filed a lawsuit against OSI Pharmaceuticals for rejecting its tender offer, but will this strategy work?
Regulatory
FDA Gives Red Light to Ranbaxy for Generic Flomax
The Indian generic firm Ranbaxy was dealt another blow this week as its version of the enlarged prostate drug Flomax was denied approval in the US just as it was about to go to market.
Marketing
Web Infinity—And Beyond!
Three ad agencies came up with two similarly designed ways of keeping track of online healthcare conversation, harnessing the power of social media sites like Twitter and Digg.
Global
Nothing is Rotten in the State of Denmark
Denmark is still on the fringes of some European Union policies. Notably, it has not yet embraced the euro as a currency, and it keeps its distance from the common defense policy. But in one respect, its pharmaceutical industry has just shown that it is well abreast—and even ahead—of EU developments.
Safety
US and Europe At Risk from Substandard Medicines
Recently, the public and policymakers have become more aware of the issue of counterfeit medicines — especially as patients increasingly learn about how to shop safely online for pharmaceuticals. But scant attention has been paid to a safety issue that is also important to patients: substandard medicines.
New & Noteworthy
Tearing Up the Rule Book
Sales compensation practices are due for an overhaul in 2010.
|
Call for Nominations
Pharmaceutical Executive¹s Emerging Pharma Leadership Award
The pharma industry is facing some tough times‹and the old way of doing things just won¹t work. So just who are the new leaders steering the industry though its most difficult challenges? Which executives are revamping the industry‹through pure innovation‹to remake it for the 21st century?
These emerging leaders are vital to the future of the industry, and you can help ensure that they get the recognition they deserve. Fill out your nomination today! |
 |
|  Simcere Pharmaceutical Group hired Yehong Zhang as president.
// Mylan appointed John Sheehan EVP and CFO.
// Kinex Pharmaceuticals hired Rudolf Kwan as chief medical officer.
// Terry Nida joined Transdel Pharmaceuticals as chief business officer.
// Zogenix added Ann Rhoads as CFO.
// Garnet BioTherapeutics hired Sanjay Batra as SVP of development.
// Archimedes Pharma appointed Jeffrey Buchalter president and CEO.
// Orexigen Therapeutics added Peter Honig to its board.
// Aethlon named John Salvador director of corporate communications.
// Catalyst Biosciences appointed William Dawson CFO.
// Regenesis Biomedical added Peter Sheehan to its board and named him chairman of its medical advisory board.
//
|
Advertisement:
2nd Annual Bio/Pharmaceutical Drug Safety Forum
Employ Benchmarks for Benefit/Risk Analysis, REMS Implementation and AssessmentTop of Form
March 15 - 16, 2010
Philadelphia, PA
 www.cbinet.com/drugsafety
Mention Promo Code: FJY443 and Save $200 (Cannot be combined with other offers or used toward a current registration)
|
Feb 23 –25, 2010 BIO-Windhover/Pharmaceutical Strategic Outlook, New York, NY
April 12–14, 2010 19th Annual Partnerships in Clinical Trials, Orlando FL
April 20 –22, 2010 INTERPHEX, New York, NY
June 13–17, 2010 Drug Industry Association’s Annual Meeting, Washington DC |
|
|
|
 |
|
 |
|
 |
| Will open-source research and development have a positive effect on the industry? |
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe
from this list click
here.To
ensure delivery to your Inbox, please add %%email.list%% to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
